Skip to main content
. 2011 Sep 20;105(9):1253–1259. doi: 10.1038/bjc.2011.362

Table 2. Intestinal stem and cancer stem cell markers.

Marker Type of crypt cell marked Proof of stemnessa Proof of cancer stemness Number of cells required for tumour growthb
CD24 All lower crypt cells Organoid growth Megacolonies Xenotransplant N/A
CD44 Lower crypt cells except Paneth cells Expression profile Megacolonies Xenotransplant 200–500c
CD133 All lower crypt cells In vivo lineage tracing Xenotransplant 3000c, 262d
CD166 Intercalated crypt base cells and Paneth cells Expression profile Immunofluorescence FACS Xenotransplant 1000–4000c
Lgr5 Intercalated crypt base cells In vivo lineage tracing Targeted Apc deletion N/A
Olfm4 Intercalated crypt base cells In situ hybridisation In situ hybridisation N/A
Aldh1 Isolated crypt base cells Immunofluorescence Xenotransplant 25e
Integrins All lower 1/3 crypt cells (β1 integrin) Colony forming assay N/A N/A
Bmi1 +4 Single supra-Paneth cell In vivo lineage tracing N/A N/A
Musashi1 Intercalated crypt base and supra-Paneth cells Immunohistochemistry N/A N/A

Abbreviations: FACS=fluorescence-activated cell sorting; NOD/SCID=non-obese diabetic/severe combined immunodeficient.

a

Strongest evidence quoted.

b

In NOD/SCID mice.